Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects
Clinical trial NCT02508896 · COMPLETED
Trial details
- NCT number
- NCT02508896
- Sponsor
- Affiris AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-05-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.